Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cellcura ASA appoints Tore Viana-Ronningen as new interim CEO


Friday, 17 Jan 2014 03:29am EST 

Cellcura ASA:Says Tore Kvam and the Board of Directors in the company have jointly decided that Tore Kvam will resign from his position as interim Chief Executive Officer (CEO) with effect from Jan. 17.Says Tore Viana-Ronningen has been hired as interim CEO with effect from Jan. 20. 

Company Quote

2.41
0.02 +0.84%
7 Jul 2014